Introduction {#s1}
============

The coccidian parasite *Toxoplasma gondii (T. gondii)* causes infections in humans worldwide \[[@R01]\]. Cats are the definitive host of *T. gondii*, whereas humans and other warm-blooded animals are intermediate hosts \[[@R02]\]. Most infections with *T. gondii* in humans are acquired by ingestion of food or water contaminated with *T. gondii* oocysts shed by cats, or by the ingestion of raw or undercooked meat containing tissue cysts \[[@R03]\]. Less frequently, infection with *T. gondii* may occur by organ transplantation \[[@R04]\], and blood transfusion \[[@R05]\]. In addition, primary infection with *T. gondii* during pregnancy may lead to vertical transmission and congenital disease \[[@R03], [@R06]\]. Infections with *T. gondii* are usually asymptomatic \[[@R03]\]. Subjects with clinical manifestations of infection (toxoplasmosis) may present with disease in eyes, lymph nodes and central nervous system \[[@R03], [@R07], [@R08]\]. Toxoplasmosis is particularly severe in immunocompromised individuals \[[@R09]\]. Common symptoms of toxoplasmosis include fatigue, headache, muscle aches, and difficulty concentrating \[[@R10]\]. Furthermore, infection with *T. gondii* has been associated with a number of psychiatric disorders including depression \[[@R11]\], schizophrenia \[[@R11], [@R12]\], impulsive aggression \[[@R13]\], generalized anxiety disorder \[[@R14]\], and suicide attempts \[[@R15]\].

Premenstrual dysphoric disorder is a severe form of premenstrual syndrome with serious psychological symptoms \[[@R16]\]. This disorder is characterized by cognitive-affective symptoms that appear in a cyclic manner during the premenstrual period \[[@R17]\]. This illness has been recently designated as a disorder in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) (http://www.dsm5.org/Pages/Default.aspx). Prevalence of premenstrual dysphoric disorder varies from 1.3% to 8% \[[@R18], [@R19]\]. Symptoms of this disorder significantly impair daily functioning \[[@R20], [@R21]\], and its etiology is unclear \[[@R16], [@R18], [@R20]\]. It raises the question whether *T. gondii* infection plays a role in this disorder as it does in other psychiatric disorders. To our knowledge, the link of *T. gondii* infection and premenstrual dysphoric disorder has not been studied. Therefore, we sought to determine the association of *T. gondii* infection with clinical characteristics of premenstrual dysphoric disorder in a sample of women in Durango City, Mexico.

Materials and Methods {#s2}
=====================

Study design and population studied {#s2a}
-----------------------------------

Through a cross-sectional study, we examined 151 women with premenstrual dysphoric disorder. Women studied were enrolled in two public primary healthcare centers: Centro de Salud \#2 of the Secretary of Health (n = 78), and Clinic of Family Medicine of the Institute of Security and Social Services of State Workers (n = 73) in the northern Mexican city of Durango. Participants were examined from February to April 2016. Inclusion criteria for enrollment were women suffering from premenstrual dysphoric disorder, aged 30 - 40 years old, and who accepted to participate in the study. Diagnosis of premenstrual dysphoric disorder was made according to the DSM-5 criteria \[[@R22]\]. Occupation, civil status, and socioeconomic level of women were not restrictive criteria for enrollment. Pregnant women were not included in the study. Mean age in women examined was 35.52 ± 3.59.

Clinical data of the women studied {#s2b}
----------------------------------

Signs and symptoms of women were obtained with the aid of a questionnaire. In total, 59 clinical characteristics of women were recorded including presence of irregular periods, severity of menstruation, vaginal infections, painful periods, fatigue, memory lapses, difficulty concentrating, confusion, judgment problems, suffering from mental illness, mood changes, low self-esteem, depression, guilty feeling, increase of fears, panic attacks, anxiety, tension, nervousness, irritability, aggressiveness, lack of interest in daily activities, lack of interest in social relations, out of control feeling or overwhelmed, reduced tolerance to noises and lights, dizziness, headache, migraine, allergy, breast pain, arterial hypertension, bouts of rapid heartbeat, decrease in muscle power, joint pain, low back pain, muscle tension, clumsiness, tingling extremities, electric shock sensation, bruises, edema in ankles, hands or feet, decreased libido, increased libido, dyspareunia, abdominal bloating, gas, abdominal pain, constipation, diarrhea, nauseas, abdominal inflammation, appetite disturbance, desire to eat certain food or eat a lot, weight gain, respiratory problems, presence of acne, presence of herpes labialis, sleep problems, thyroid disease, and obesity.

Detection of anti-*T. gondii* IgG and IgM antibodies {#s2c}
----------------------------------------------------

A serum sample from each woman was obtained. Serum samples were stored at -20 °C until analyzed. Anti-*T. gondii* IgG antibodies were detected in serum samples with the commercially available enzyme immunoassay (EIA) kit "*Toxoplasma* IgG" (Diagnostic Automation/Cortez Diagnostics Inc., Woodland Hills, CA, USA). This kit was also used to quantitate the IgG levels. Anti-*T. gondii* IgG antibody levels were expressed as International Units (IU)/mL. A cut off of ≥ 8 IU/mL of IgG was used for seropositivity. Sera reactive for anti-*T. gondii* IgG antibodies were further analyzed for anti-*T. gondii* IgM antibodies by the commercially available EIA "*Toxoplasma* IgM" kit (Diagnostic Automation/Cortez Diagnostics Inc.). All EIAs were performed following the instructions of the manufacturer.

Detection of *T. gondii* DNA {#s2d}
----------------------------

Whole blood of women with anti-*T. gondii* IgG antibodies was analyzed to detect *T. gondii* DNA by nested-polymerase chain reaction (PCR). DNA of whole blood was extracted following a protocol describe elsewhere (http://www.protocol-online.org/prot/Protocols/Rapid-Extraction-of-High-Quality-DNA-from-Whole-Blood-Stored-at-4-C-for-Long-Period-4175.html). Primers directed against the B1 gene of *T. gondii* and a PCR protocol previously described \[[@R23]\] were used. Sensitivity and specificity of this test were previously examined \[[@R24]\]. Amplification products were analyzed by electrophoresis using 2% agarose gels, stained with ethidium bromide, and visualized using ultraviolet illumination.

Statistical analysis {#s2e}
--------------------

Results were analyzed with the aid of the software SPSS 15.0 (SPSS Inc. Chicago, IL), Microsoft Excel, and Epi Info 7. For calculation of the sample size, we used: 1) a reference seroprevalence of 6.1% \[[@R25]\] as the expected frequency for the factor under study, 2) 100,000 as the population size from which the sample was selected, 3) a 4.0% of confidence limits, and 4) a 95% confidence level. The result of the sample size calculation was 137 subjects. The association of *T. gondii* infection and the clinical characteristics of women was assessed with the Pearson's Chi-squared test or the two-tailed Fisher's exact test (when values were five or less). In the multivariate analysis, we included only variables with a P value ≤ 0.20 obtained in the bivariate analysis. We calculated odds ratio (OR) and 95% confidence interval (CI) using logistic regression with the Enter method. A P value less than 0.05 was considered statistically significant.

Ethical aspects {#s2f}
---------------

This study was approved by the Ethics Committees of the General Hospital of the Secretary of Health, and the Institute of Security and Social Services of State Workers in Durango City, Mexico. Participation of women was voluntary. The purpose and procedures of this study were explained to all participants, and a written informed consent was obtained from all of them.

Results {#s3}
=======

Anti-*T. gondii* IgG antibodies were found in 10 (6.6%) of the 151 women with premenstrual dysphoric disorder studied. Of the 10 anti-*T. gondii* IgG positive women, five (50.0%) had IgG levels \> 150 IU/mL, two (20.0%) between 100 and 150 IU/mL, and three (30.0%) between 8 and 99 IU/mL. Anti-*T. gondii* IgM antibodies were found in four (40.0%) of the 10 IgG seropositive women. DNA of *T. gondii* was detected in one (10.0%) of the 10 women with IgG antibodies against *T. gondii*. IgG levels in this women were 146 IU/mL.

Women seropositive to anti-*T. gondii* IgG antibodies showed from 13 to 40 (mean: 25.8 ± 7.58) signs or symptoms, whereas seronegative women (n = 141) had from 7 to 48 (mean: 29.22 ± 9.13) signs or symptoms. Mean number of clinical characteristics in seropositive women was similar to that found in seronegative women (P = 0.25).

Concerning clinical characteristics, bivariate analysis showed seven variables potentially (P ≤ 0.20) associated with IgG seropositivity to *T. gondii*: irregular periods, difficulty concentrating, low self-esteem, guilty feeling, increase of fears, out of control feeling or overwhelmed, and tingling extremities. Other clinical characteristics studied showed P values higher than 0.20 by bivariate analysis. Results of bivariate analysis of a selection of clinical characteristics of women and IgG seropositivity to *T. gondii* are shown in [Table 1](#T1){ref-type="table"}. Further analysis by logistic regression of variables with P ≤ 0.20 obtained by bivariate analysis showed that seropositivity to *T. gondii* was negatively associated with difficulty concentrating (OR: 0.18; 95% CI: 0.03 - 0.91; P = 0.03), and positively associated with out of control feeling or overwhelmed (OR: 9.00; 95% CI: 1.32 - 62.00; P = 0.02) ([Table 2](#T2){ref-type="table"}).

###### Results of Bivariate Analysis of a Selection of Clinical Data and Seropositivity to *T. gondii*

  Characteristics                          No. of women tested   Prevalence of *T. gondii* infection   P value   
  ---------------------------------------- --------------------- ------------------------------------- --------- ------
  Irregular periods                                                                                              
    Yes                                    100                   9                                     9         0.16
    No                                     50                    1                                     2         
  Sleep problems                                                                                                 
    Yes                                    85                    4                                     4.7       0.33
    No                                     66                    6                                     9.1       
  Difficulty concentrating                                                                                       
    Yes                                    109                   4                                     3.7       0.02
    No                                     41                    6                                     14.6      
  Judgment problems                                                                                              
    Yes                                    59                    2                                     3.4       0.31
    No                                     91                    8                                     8.8       
  Mood changes                                                                                                   
    Yes                                    145                   9                                     6.2       0.29
    No                                     5                     1                                     20        
  Low self-esteem                                                                                                
    Yes                                    114                   5                                     4.4       0.06
    No                                     37                    5                                     13.5      
  Guilty feeling                                                                                                 
    Yes                                    80                    3                                     3.8       0.19
    No                                     71                    7                                     9.9       
  Increase of fears                                                                                              
    Yes                                    83                    3                                     3.6       0.11
    No                                     68                    7                                     10.3      
  Anxiety                                                                                                        
    Yes                                    103                   5                                     4.9       0.29
    No                                     48                    5                                     10.4      
  Tension                                                                                                        
    Yes                                    111                   6                                     5.4       0.45
    No                                     40                    4                                     10        
  Nervousness                                                                                                    
    Yes                                    119                   7                                     5.9       0.44
    No                                     32                    3                                     9.4       
  Irritability                                                                                                   
    Yes                                    124                   7                                     5.6       0.38
    No                                     27                    3                                     11.1      
  Lack of interest in social relations                                                                           
    Yes                                    92                    8                                     8.7       0.31
    No                                     59                    2                                     3.4       
  Out of control feeling or overwhelmed                                                                          
    Yes                                    86                    8                                     9.3       0.18
    No                                     65                    2                                     3.1       
  Reduced tolerance to noises and lights                                                                         
    Yes                                    89                    4                                     4.5       0.31
    No                                     62                    6                                     9.7       
  Joint pain                                                                                                     
    Yes                                    96                    8                                     8.3       0.32
    No                                     55                    2                                     3.6       
  Low back pain                                                                                                  
    Yes                                    117                   9                                     7.7       0.45
    No                                     34                    1                                     2.9       
  Tingling extremities                                                                                           
    Yes                                    96                    4                                     4.2       0.17
    No                                     55                    6                                     10.9      
  Decreased libido                                                                                               
    Yes                                    81                    7                                     8.6       0.34
    No                                     68                    3                                     4.4       
  Dyspareunia                                                                                                    
    Yes                                    42                    1                                     2.4       0.28
    No                                     108                   9                                     8.3       
  Presence of acne                                                                                               
    Yes                                    85                    4                                     4.7       0.33
    No                                     65                    6                                     9.2       

\*Sum may not add up to 151 because of missing values.

###### Results of the Multivariate Analysis of Clinical Characteristics and IgG Seropositivity to *T. gondii*

  Characteristics                         Odds ratio   95% confidence interval   P value
  --------------------------------------- ------------ ------------------------- ---------
  Irregular periods                       7.91         0.75 - 82.5               0.08
  Difficulty concentrating                0.18         0.03 - 0.91               0.03
  Low self-esteem                         0.48         0.08 - 2.57               0.39
  Guilty feeling                          0.45         0.08 - 2.46               0.36
  Increase of fears                       0.58         0.11 - 3.10               0.53
  Out of control feeling or overwhelmed   9.00         1.32 - 62.0               0.02
  Tingling extremities                    0.40         0.08 - 1.86               0.24

Bivariate analysis showed that the prevalence of high (\> 150 IU/mL) IgG levels to *T. gondii* was significantly (P = 0.02) lower in women with difficulty concentrating (1/109: 0.9%) than in those without this clinical feature (4/41: 9.8%). Whereas prevalence of high IgG levels was higher, but not statistically significant (P = 0.07), in women suffering from out of control feeling or overwhelmed (5/86: 5.8%) than in those without this clinical characteristic (0/65: 0%). Concerning the association of clinical data and seropositivity to both anti-*T. gondii* IgG and IgM antibodies, bivariate analysis showed no significant associations. DNA of *T. gondii* was found in only one woman who was seropositive to anti-*T. gondii* IgG antibodies. Due to a limited number of cases with high IgG levels, seropositivity to IgM, and positivity to *T. gondii* DNA, no further regression analysis of the association of these laboratory results and the clinical variables was performed.

Discussion {#s4}
==========

Premenstrual dysphoric disorder is a clinical entity of unclear pathogenesis \[[@R18]\]. This psychiatric disorder is currently affecting up to 8% of women at reproductive age and focuses on psychological symptoms, whereas physical symptoms prevail in premenstrual syndrome \[[@R21]\]. Infection with *T. gondii* leads to a wide parasite spread in the host from the intestine to many organs in the body including the brain \[[@R26]\]. Infection with *T. gondii* has been associated with psychiatric disorders in general \[[@R27], [@R28]\], and it has been linked to changes in behavior \[[@R29], [@R30]\]. To our knowledge, the association between *T. gondii* infection and signs and symptoms of premenstrual dysphoric disorder was not assessed previously. Therefore, the present work aimed to determine whether infection with *T. gondii* was associated with clinical characteristics of premenstrual dysphoric disorder in a sample of women in the northern Mexican city of Durango. We observed that women with *T. gondii* IgG antibodies had a similar mean number of signs or symptoms to seronegative women. Nevertheless, multivariate analysis showed that seropositivity to *T. gondii* is associated with specific clinical characteristics of premenstrual dysphoric disorder in particular. Interestingly, IgG seropositivity to *T. gondii* was associated with the clinical manifestation of out of control feeling or overwhelmed. It is not clear why infection with *T. gondii* was associated with this psychological symptom in women with premenstrual dysphoric disorder. We did not find any report in the medical literature about the association of *T. gondii* and the clinical manifestation of out of control feeling or overwhelmed. The subjective sense of being overwhelmed or out of control has been recognized as a diagnostic symptom of premenstrual dysphoric disorder for about 20 years \[[@R31]\]. In a retrospective study of Brazilian college students, researchers found that out of control feeling or overwhelmed were major symptoms of premenstrual dysphoric disorder \[[@R32]\]. Brazil has a high (64.9%) prevalence of *T. gondii* infection among women of childbearing age \[[@R33]\], and our finding raises the question whether *T. gondii* might be linked to these symptoms in Brazilian women with premenstrual dysphoric disorder. In a study in Casablanca, Morocco, researchers found that the subjective sense of being overwhelmed or out of control was present in 55.7% of women with premenstrual dysphoric disorder studied \[[@R34]\]. We may hypothesize that *T. gondii* in brain may lead to psychological symptoms as out of control feeling or overwhelmed in women suffering from premenstrual dysphoric disorder. Infection with *T. gondii* may cause changes in neurotransmitters, i.e., dopamine and serotonin, that could lead to mood and behavioral changes \[[@R11], [@R35]\]. On the other hand, in the present study, infection with *T. gondii* was negatively associated with difficulty concentrating. This finding suggests a protective effect of *T. gondii* on this clinical characteristic. Nevertheless, this finding may also suggest that *T. gondii* was not an important factor for this symptom in women with premenstrual dysphoric disorder. Difficulty concentrating has been linked to *T. gondii* infection in immunocompetent adult patients suffering from acute toxoplasmic lymphadenitis \[[@R10]\]. Difference in results among the studies might be explained by difference in the characteristics of the patients studied including clinical diagnosis of patients, duration of infection (acute vs. chronic), and gender.

This study has limitations including small sample size of women with premenstrual dysphoric disorder and a low frequency of anti-*T. gondii* IgG, IgM and PCR positivity. In addition, criteria for diagnosis of this disorder have been recently described, and it is unclear whether this disorder requires further characterization. For the above reasons results of the present study should be interpreted with care.

Conclusions {#s4a}
-----------

Results of this first study on the association of *T. gondii* infection and clinical characteristics of premenstrual dysphoric disorder suggest that this infection might be linked to some symptoms of this disorder. We report for the first time the association of *T. gondii* infection and out of control feeling or overwhelmed. Results warrant for further research on the role of *T. gondii* in premenstrual dysphoric disorder.
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